Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Hamamatsu Photonics IR-Enhanced Silicon Avalanche Photodiodes
Tuesday, July 03, 2012
Company introduces new range of silicon detectors and image sensors.

Scienion’s sciFLEXARRAYER S11 to be Used by Courtagen
Tuesday, June 26, 2012
Courtagen will use sciFLEXARRAYER technology for the production of QPDx® biochips.

New Chip Measures Viscosity Up to 2,000,000 Reciprocal Seconds!
Monday, June 25, 2012
New E chip is more stable and more accurate.

Rapid, Reliable Isolation and Processing of Individual Cells for Genomic Analysis
Monday, June 25, 2012
Fluidigm releases new C1™ Single-Cell AutoPrep system at ISSCR meeting in Japan.

Advion Launches Chip-Mate™
Monday, June 18, 2012
Company launches an affordable and easy-to-use chip-based nano-LC Ion Source, at ASMS 2012.

Dolomite Launches New Microfluidic Interface
Thursday, June 14, 2012
Flexible and fast solution for PDMS chip connections.

New First of its Kind Constant Pressure Fluid Delivery Syringe Pump
Wednesday, June 06, 2012
New PHD ULTRA™ CP syringe pump to infuse fluids under constant pressure.

ZyGEM and Lockheed Martin Announce Early Release for Rapid DNA Platform
Thursday, May 31, 2012
Companies unveil key component at leading forensics science meeting.

Bio-Rad Introduces First ProteOn™ Sensor Chip
Thursday, May 24, 2012
Product capable of label-free interaction analysis of membrane proteins with peptides and small molecules.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1043
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed